KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Accumulated Expenses (2016 - 2025)

Chemed (CHE) has 17 years of Accumulated Expenses data on record, last reported at $58.3 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 36.65% year-over-year to $58.3 million; the TTM value through Dec 2025 reached $58.3 million, down 36.65%, while the annual FY2025 figure was $58.3 million, 36.65% down from the prior year.
  • Accumulated Expenses reached $58.3 million in Q4 2025 per CHE's latest filing, down from $79.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $97.3 million in Q3 2021 and bottomed at $49.8 million in Q1 2024.
  • Average Accumulated Expenses over 5 years is $73.5 million, with a median of $74.1 million recorded in 2021.
  • The widest YoY moves for Accumulated Expenses: up 20.29% in 2025, down 36.65% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $95.6 million in 2021, then fell by 8.63% to $87.4 million in 2022, then grew by 1.18% to $88.4 million in 2023, then rose by 4.18% to $92.1 million in 2024, then tumbled by 36.65% to $58.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $58.3 million in Q4 2025, $79.7 million in Q3 2025, and $54.7 million in Q2 2025.